Truly honored to be asked back to support this year's Midwest AMCP day of education - Chicago! It is an impressive agenda, and I am excited to be moderating a panel with these fellow pharmacy experts. Megan Wagner, Alex J. and Greg Baker! It's just a week away - registration information below! Looking forward to seeing so many colleagues, friends and industry experts - see you there!
read full article ›Eli Lilly's press release yesterday about Zepbound's approval is another example of a pharma using regulatory news to address pricing and product access head on. Like Brian Reid of The Cost Curve newsletter, we think this kind of transparency can be beneficial, allowing a company to have greater control over the value narrative.
read full article ›Unleash the beast! The potential payor dynamics and impact surrounding the obesity market will have a profound impact on pricing and reimbursement issues in this category and beyond. Look out for some interesting pricing battles in the days to come.
read full article ›We are so excited to announce that Jeff Parish has joined Real Endpoints. Jeff's deep consultative business development experience will accelerate our next phase of growth and further deepen our client relationships as we continue to develop new solutions to achieve market access for innovative products.
read full article ›Very excited to be attending the Digital Health Summit on 10/25 - hosted by The Center of Technology and Behavior Health. To learn more, see below. Rob O'Brien will be hosting a panel discussion focused on, the value proposition of digital therapeutics and paths to deployment and strategies to achieve payer buy-in. Have an all-star panel that includes...Reena Pande, Jason Parent, MSN, APRN, FNP-C, Jeffrey Abraham, Brendan Hare! Looking forward to the great agenda and connecting with the various stakeholders attending!
read full article ›We are thrilled that RE Assist was named as a finalist in the Financial/Operational Solutions category of the 2023 Fierce Healthcare Innovation Awards. It's a validation of Real Endpoints work to create a tangible solution for #copay challenges faced by #Medicare patients. To our fellow finalists - congratulations! It's an honor to be in such exalted company.
read full article ›An Bloomberg Opinion article by Lisa Jarvis highlights the economic challenges of paying for new cell and gene therapies. Given the cost of development and, more importantly, the cost of goods, these therapies are necessarily expensive, and will be for a long time. New financial engineering solutions, which she writes about, are hardly going to solve the problem – someone will pay the cost. And government intervention is a long way off.
read full article ›In case you missed it, Real Endpoints Julia Murphy provided some great intel on strategies to equip pharma #FieldSalesTeam to drive meaningful #PatientOutcomes in this webinar. You can catch the replay here: https://lnkd.in/eD5SwsSn Thanks to Phil, Inc. for including us in the discussion.
read full article ›Real Endpoints Rob O'Brien met with payer and pharmacy peeps last week to get the skinny on management of weight loss meds (among other topics). Given their budget busting potential AND the demonstrated efficacy of these products, this is an area to watch.
read full article ›In a presentation designed to make people stop and think, Jeff Berkowitz outlined how a sophisticated understanding of market access is key to commercial success for biotechs. "You can do great science and great medicine - and still lose your shirt," he told the audience. Far from being a "gloomy gus," he also gave concrete advice about what to do in an environment where payers have more leverage. Key actions: ensure market access is appropriately resourced and that CEOs and leadership teams are accountable for it.
read full article ›